ReviewReviews in cardiovascular medicine2025
Shared Experiences With Guidewire Application in Chronic Total Occlusion: Technological Advances and Clinical Implications.
Review in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical outcomes of drug-coated balloonsCardiovascular diagnosis and therapy · 2026Article
- Iatrogenic coronary artery dissection: detection, management, and prevention.Frontiers in cardiovascular medicine · 2026Review
- Effects of Shexiang Baoxin pill combined with exercise rehabilitation training on long-term prognosis of CTO-PCI patients: study protocol for randomized controlled trial.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic total occlusion (CTO) poses a significant challenge in cardiovascular interventional therapy, owing to the complexity and difficulty involved, which limit the effectiveness of traditional treatment methods. Thus, innovative designs and application concepts of guidewires have expanded the possibilities for clinical intervention, resulting in significant improvements in treatment strategies for CTO. Recently, numerous studies have detailed the application experiences of various guidewires in CTO interventional therapy, including the performance characteristics, selection strategies, and differences in clinical outcomes. Nevertheless, despite these advancements, limitations remain in CTO treatment, such as low success rates and the risk of complications. Therefore, this article aims to review the current application experience of CTO guidewires. Moreover, by reviewing existing literature and summarizing clinical practices, this paper explores strategies to optimize guidewire selection and usage to enhance the success rate and safety of CTO interventional therapy and provide practical guidance for clinicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.